BioCentury | Sep 13, 2019
Finance

After single exit, Avalon seeks path forward for build-to-buy assets from GSK deal

...Calif.), which houses all of the start-ups, are cardiovascular play Adrenergics Inc., epithelial cancer company CadheRx Therapeutics Inc....
BioCentury | Aug 17, 2017
Finance

Built to purpose

...iron overload disorders, and PDI Therapeutics Inc. is targeting PDI for cancer. The fifth start-up, CadheRx Therapeutics Inc....
...Ceased operations Adrenergics Inc. GlaxoSmithKline plc Avalon Ventures Cardiovascular Single target 2015 ND Ceased operations CadheRx Therapeutics Inc....
BioCentury | Jun 22, 2015
Company News

Adrenergics, CadheRx Therapeutics, Calporta Therapeutics, GlaxoSmithKline cancer, cardiology, endocrine/metabolic news

...of a clinical candidate (see BioCentury, Sept. 29, 2014). Adrenergics Inc. , San Diego, Calif. CadheRx Therapeutics Inc....
BioCentury | Jun 22, 2015
Financial News

CadheRx Therapeutics completes venture financing

CadheRx Therapeutics Inc. , San Diego, Calif. Business: Cancer Date completed: 2015-06-15 Type: Venture financing Raised: $3 million Investors: Avalon Ventures; GlaxoSmithKline plc WIR Staff cancer...
BioCentury | Jun 22, 2015
Finance

Build-to-buy basket

...that is homegrown by the VC. The newest cohort of companies includes Adrenergics Inc. , CadheRx Therapeutics Inc....
BioCentury | Jun 16, 2015
Financial News

Avalon, GSK launch three more biotechs

...and $7 million in R&D support. Adrenergics Inc. is focused on therapies for dilated cardiomyopathy. CadheRx Therapeutics Inc....
Items per page:
1 - 6 of 6
BioCentury | Sep 13, 2019
Finance

After single exit, Avalon seeks path forward for build-to-buy assets from GSK deal

...Calif.), which houses all of the start-ups, are cardiovascular play Adrenergics Inc., epithelial cancer company CadheRx Therapeutics Inc....
BioCentury | Aug 17, 2017
Finance

Built to purpose

...iron overload disorders, and PDI Therapeutics Inc. is targeting PDI for cancer. The fifth start-up, CadheRx Therapeutics Inc....
...Ceased operations Adrenergics Inc. GlaxoSmithKline plc Avalon Ventures Cardiovascular Single target 2015 ND Ceased operations CadheRx Therapeutics Inc....
BioCentury | Jun 22, 2015
Company News

Adrenergics, CadheRx Therapeutics, Calporta Therapeutics, GlaxoSmithKline cancer, cardiology, endocrine/metabolic news

...of a clinical candidate (see BioCentury, Sept. 29, 2014). Adrenergics Inc. , San Diego, Calif. CadheRx Therapeutics Inc....
BioCentury | Jun 22, 2015
Financial News

CadheRx Therapeutics completes venture financing

CadheRx Therapeutics Inc. , San Diego, Calif. Business: Cancer Date completed: 2015-06-15 Type: Venture financing Raised: $3 million Investors: Avalon Ventures; GlaxoSmithKline plc WIR Staff cancer...
BioCentury | Jun 22, 2015
Finance

Build-to-buy basket

...that is homegrown by the VC. The newest cohort of companies includes Adrenergics Inc. , CadheRx Therapeutics Inc....
BioCentury | Jun 16, 2015
Financial News

Avalon, GSK launch three more biotechs

...and $7 million in R&D support. Adrenergics Inc. is focused on therapies for dilated cardiomyopathy. CadheRx Therapeutics Inc....
Items per page:
1 - 6 of 6